Thoracoabdominal Aortic Aneurysms
ConditionThoracoabdominal Aortic Aneurysm
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAssiut University
About this trial
Evaluation of the effectiveness of the different modalities for treatment of thoracoabdominal aortic aneurysms. FEVAR and BEVAR devices are widely used now due to its feasability and wide range of use . We aim to evaluate the effectiveness of these new devices in the management of TAAA
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
all adult consecutive patients presenting with TAAA larger than 5.5 cm
Disqualifiers
active infection Asymptomatic patients with small aneurysms Allergy to contrast agents
Trial population
Adult patients
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Fenestrated and branched endovascular devices for TAAA
DeviceDevices for TAAA
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Successful cannulation of the target vessels with complete in-line flow to target organs.
No ischemia
Time frame
Two yearsLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: